NCT04860869View on ClinicalTrials.gov

Endocrine, Metabolic and Microbiome Influence on the Post-acute Sequelae SARS-CoV-2 (PASC)

CompletedOBSERVATIONAL

Enrollment

23

Participants

Timeline

Start Date

May 12, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions

Covid19

Trial Locations (1)

77555

The University of Texas Medical Branch, Galveston

All Listed Sponsors

lead

The University of Texas Medical Branch, Galveston

OTHER